In non-small cell lung cancer (NSCLC), PACE4 expression in tissues was previously reported to carry a prognostic value regarding patient survival, patient with high PACE4 being having worsened prognostic21. This evidence concerns the gene PCSK6 and non-small cell lung carcinoma.